Current stock page

Catalysts

AMGN Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareDrug Manufacturers - GeneralScore data as of Oct 30, 2026

AMGNAmgen Inc.

Healthcare / Drug Manufacturers - General

Relative Leader / Watch

Strong Relative Position

NeutralEdge 8/10
$466.01+$5.28 (+1.15%)

Latest quote

  • Momentum
    88
  • Value
    44
  • Quality
    70
  • Risk resilience
    47
  • Sentiment
    56
algovestiq.comScore data as of Oct 30, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Nov 3, 2026

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 63/100

Momentum 88/100 and sentiment 56/100 before the next covered event.

Recent coverage
4 articles

Updated Oct 30, 2026 · Sentiment 25.59%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 88/100AIQ Edge 8/10 Strong Relative Position
Beat rate
100%
4 of 4 reported periods
Average surprise
+11.0%
Across covered historical reports
Latest result
+11.9%
Aug 4, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 3, 2026—$5.79——$10.05B—
Aug 4, 2026—$5.62$6.29+11.9%$9.43B$10.05B
Apr 30, 2026—$4.77$5.15+8.0%$8.58B$8.62B
Feb 3, 2026—$4.73$5.29+11.8%$9.47B$9.87B
Nov 4, 2025—$5.02$5.64+12.4%$8.97B$9.56B

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Hold
12
Buy
17
Hold
5
Sell
12-month analyst target
$396.97
-14.82% versus current price
Based on 19 analyst observations. Targets are estimates, not predictions.
Low target
$230.00
-50.64% vs latest price
Average target
$396.97
-14.82% vs latest price
High target
$500.00
+7.29% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateNov 3, 2026

Next known earnings or reporting date.

EPS estimate$5.79

Current analyst expectation for the upcoming report.

Revenue estimate$10.07B

Current analyst expectation for the upcoming report.

Sentiment score56

News pressure around the setup.

Momentum score88

Where event reaction would show up first.

AIQ score63/100

Composite decision read before event confirmation.

Analyst context

Consensus
Hold
Analysts
19
Average target
$396.97
Target upside
-14.82%
Target range
$230.00 - $500.00
90-day revisions
6

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
3
Neutral
1
Negative
0
gurufocus.com · Oct 28, 2026

FDA Flags Amgen's VECTIBIX Ad for Misleading Content, AMGN Stock Reacts

On October 28, 2026, the U.S. Food and Drug Administration (FDA) raised concerns about a promotional video for Amgen Inc's (NASDAQ: AMGN) VECTIBIX Injection, de

seekingalpha.com · Oct 27, 2026

Amgen Stock: A Biotech Bargain Heading Into Q3 Earnings (NASDAQ:AMGN)

Amgen Inc.’s Q3 is near. Explore EPS growth, pipeline momentum, valuation, and dividend yield to see why it offers good risk/reward. Click for this AMGN update.

gurufocus.com · Oct 27, 2026

Amgen (AMGN) Appoints Former Yum! Brands CEO David W. Gibbs to Board of Directors

Amgen Inc. (AMGN) announced that its Board of Directors has appointed David W. Gibbs as a director of the company, effective immediately. The appointment expan

gurufocus.com · Oct 26, 2026

Is AMGN Overvalued? DCF Says Worth $204

On October 26, 2026, we conducted a DCF analysis for Amgen Inc (AMGN), a company that has shown strong price performance recently, with a year-to-date increase

Open full news and sentiment

AMGN Catalysts FAQ

What are the next catalysts for AMGN stock?

AMGN's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move AMGN stock?

Upcoming events that could move AMGN include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could AMGN's next earnings report affect the stock?

AMGN's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive AMGN stock higher?

AMGN could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt AMGN stock?

AMGN could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.